A Double-Blind, Randomized, Placebo-controlled, Phase 1 Dose Escalation Trial to Evaluate the Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine, HydroVax-001, in Healthy Adults

Research Grant

Duke Scholars

Co-Principal Investigator Christopher Wildrick Woods Medicine, Infectious Diseases

Principal Investigator Emmanuel Benjamin Walter Jr. Pediatrics, General Pediatrics and Adolescent Health

Investigator Micah Thomas McClain Medicine, Infectious Diseases

Administered By

Duke Human Vaccine Institute

Awarded By

National Institutes of Health

Start Date

November 10, 2014

End Date

February 28, 2018

Administered By

Duke Human Vaccine Institute

Awarded By

National Institutes of Health

Start Date

November 10, 2014

End Date

February 28, 2018